Abstract. The inflammatory response to intraarticular urate crystals is known to be variable in gouty arthritis. One source ofvariability may be the modulation of cellular responses by crystal-bound proteins. We have identified three apolipoproteins among the polypeptides bound to urate crystals exposed to plasma. Identification was first based on their coelectrophoresis with polypeptides from isolated lipoproteins and diminution in the protein coat of crystals exposed to lipoprotein-depleted plasma. Immunodepletion from plasma of all apo B lipoproteins by agarose-bound apo B-specific antibody also removed all inhibitory activity for urate-induced CL. Thus, apo B lipoproteins were shown to be the inhibitory species in plasma. Binding of apo B lipoproteins to urate crystals and inhibition of CL was also seen in the absence of other plasma proteins. In addition, the binding of whole lipoprotein particles to the crystals was verified by detection of crystal-associated cholesterol in addition to the apoprotein.
Introduction
Monosodium urate crystals appear to trigger attacks ofgout (1) ; yet there is striking variability in the inflammatory response to intra-articular crystals (2) (3) (4) (5) . The ability of urate crystals to induce inflammation is critically dependent upon neutrophils (6) . In response to urate crystals, these cells generate superoxide (7, 8) , a chemotactic factor (9, 10) , and leukotrienes (1 1), and release lysosomal enzymes by lytic and nonlytic (12, 13) mechanisms. A number of biologically significant proteins bind to urate crystals (14) (15) (16) (17) and may influence crystal-induced neutrophil responses (7, 18) . This suggests that variation in the protein coat of these crystals may be one factor in the variable in vivo inflammatory response in gout.
Since most synovial fluid proteins are present in plasma (19) , and plasma and serum have a more constant composition than gouty synovial fluid (19, 20) , investigators have focused on serum and plasma effects on neutrophil-crystal interaction. Serum profoundly inhibits urate crystal-induced neutrophil lysis (18) and a serum coat has been shown by Abramson et al. (7) to reduce urate crystal-induced superoxide generation. In neither study were the inhibitory factor(s) identified. We have recently established detailed biochemical maps of the protein coat of plasma-exposed urate crystals by O'Farrell two-dimensional gel electrophoresis (17) and observed several hitherto unidentified polypeptides, which were increased on the crystal surface relative to plasma. In the present study, we have identified a number of these polypeptides as derived from lipoproteins. We have also found that lipoproteins containing apoprotein B (apo B)l account for virtually all of the inhibitory activity of plasma on urate crystal-induced neutrophil chemiluminescence and a major portion of the plasma inhibitory activity in urate-induced neutrophil superoxide generation and cytolysis.
Methods
Crystals and crystal-protein binding studies. Urate crystals were prepared under sterile pyrogen-free conditions by a previously described modification (21) of the method of McCarty and Faires (22) and by the method of Deniko and Whitehouse (23) and resuspended to 25 mg/ml in urate-saturated phosphate-buffered saline (PBS) (10mM Na phosphate buffer, pH 7.4, containing 150 mM NaCG) prepared as previously de- scribed (24) . Crystals were utilized in unheated form, were negatively birefringent, and ranged predominantly from 15-45 pm in length. Using polarized light microscopy, it was verified that the smaller crystals in these preparations could be phagocytosed by neutrophils. To coat crystals with plasma proteins, equal volumes of crystals and plasma were coincubated at 370C for 30 min in a total volume of0.6 ml, unless otherwise indicated. Unbound plasma proteins were removed by washing the crystals through 0.8 ml of a 20% sucrose cushion followed by a wash in 1 ml urate-saturated PBS. These conditions gave reprodudble crystalprotein binding patterns on O'Farrell gels as previously described (17) . Other reagents. Opsonized zymosan was prepared by incubation of zymosan (Sigma Chemical Corp., St. Louis, MO) with normal human serum at 370C for 15 min with agitation followed by repeated washing in PBS and storage at -700C. A 200-fold excess of opsonized zymosan particles to polymorphonuclear leukocytes (PMN) was used in the chemiluminescence (CL) assay (25) . Staphylococcus aureus ATCC 25923
1. Abbreviations used in this paper: apo, apolipoprotein; apo A-I, apo B, and apo E, apolipoproteins A-I, B, and E; CL, chemiluminescence; LDH, lactic dehydrogenase; LPDP, lipoprotein-depleted plasma; PAGE, polyacrylamide gel electrophoresis; pI, isolectric point. was a generous gift from Dr. R. Proctor (University of Wisconsin, Madison, WI) and was grown, washed, and lyophilized as described (26) . The chemotactic hexapeptide FNLPNTL (N-formyl-N-leu.leu-phe-Nleu-tyr-lys) was the generous gift of Dr. L. Sklar, Scripps Clinic and Research Foundation. All other chemicals were reagent grade.
Lipoprotein depletion, isolation and iodination. Lipoprotein-depleted plasma (LPDP) was prepared by ultracentrifugation (27) . Plasma containing 20 mM EDTA was adjusted to a density of 1.25 g/cm3 with solid KBr and centrifuged at 45,000 rpm for 20 h at 40C in a fixedangle 5OTi rotor (Beckman Instruments Inc., Spinco Div., Palo Alto, CA). The lipoprotein-containing supernatant was removed and the infranatant taken as LPDP. Reconstituted LPDP was obtained by mixing the supernatant and infranatant. Both LPDP and reconstituted LPDP were dialyzed against 1 liter of 10 mM PBS, pH 7.4, which was changed twice, for a total of 18 h, and their protein concentrations measured and equalized by addition of buffer. Lipoprotein depletion was verified by >95% reduction of cholesterol content of LPDP vs. reconstituted LPDP. Lipoproteins were isolated by sequential ultracentrifugation of pooled plasma from normal fasting subjects using solid KBr for density adjustment as previously described (27) . The lipoprotein fractions included very low density lipoprotein (VLDL), d < 1.006 g/cm3; intermediate density lipoprotein (IDL), d = 1.006-1.019 g/cm3; low density lipoprotein (LDL), d = 1.019-1.063 g/cm3; and high density lipoprotein (HDL), d = 1.063-1.25 g/cm3. The fractions were dialyzed against 0.15 M NaCl containing 0.3 mM EDTA and 0.0005% alphatocopherol, filter sterilized, and stored sterile for a maximum of 7 d. All lipoprotein concentrations are expressed on the basis of protein as measured by a modification of the Lowry assay using a bovine serum albumin (BSA) standard (28) . The lipoproteins used displayed a consistent apoprotein composition as judged by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) (27) . When labeled lipoproteins were employed, 100 pg ofVLDL, IDL, LDL, and HDL were labeled enzymatically with I mCi of '25I (Amersham Corp., Arlington Heights, IL) using immobilized lactoperoxidase and glucose oxidase (Enzymobeads, Bio-Rad Laboratories, Richmond, CA). They were dialyzed, characterized, and stored aseptically in the presence of 10% BSA as previously described (29) .
Immunodepletion ofapo-B lipoproteins. Plasma was depleted ofapo B-containing lipoproteins (VLDL, IDL, and LDL) by immunoadsorption with a mouse anti-human apo B monoclonal antibody, V82A6 (27) . The monoclonal antibody was immunopurified from ascites fluid as described (29) , coupled to CNBr-activated Sepharose 4B (Pharmacia Fine Chemical, Piscataway, NJ), and equilibrated in PBS containing 10 mM EDTA, 10 U/ml trasylol, and 5 mM benzamidine. 1 ml of plasma was chromatographed on 15 ml of gel containing 26.3 mg of coupled antibody and the nonretained plasma fraction collected. Apo B removal from the plasma was monitored immunochemically by using a solidphase radioimmunoassay as described (27) . The antibody-adsorbed plasma fraction contained <50 ng apo B/mg of plasma protein.
Two-dimensional gel electrophoresis. Urate crystal-bound protein was eluted by boiling for 5 min in 10% glycerol, 5% Nonidet-40, 1 .5% SDS, and 2% fi-mercaptoethanol, and the protein concentration of the eluates was determined by the Lowry assay using a BSA standard. Samples ofpurified lipoproteins delipidated by boiling in the same SDS-containing buffer described above, and crystal eluates containing 75 pg of protein were analyzed by isoelectric focusing followed by SDS-PAGE in an 8-20% exponential gradient slab gel in the second dimension as described previously (17) . Protein was detected by the silver-staining protocol of Morrissey (30) , and isoelectric points and molecular weights estimated as described previously (17 (27) . The nitrocellulose transfers of O'Farrell gels were soaked overnight in PBS containing 3% BSA, 3% normal goat serum, and 0.01% azide (blocking buffer) to saturate remaining active binding sites, and then incubated with first antibody (hybridoma culture supernatants or ascites fluids) for 18 h at 4VC. Sources of apoprotein-specific antibody were: anti-apoprotein A-I (apo A-I) hybridoma AV63C2 (27) ; anti-apo B hybridomas V82A6 and V82B1 (27) ; monospecific rabbit polyclonal anti-LDL serum (29) , and anti-apoprotein E (apo E), hybridoma Emab3 (31) . The nitrocellulose membranes were washed five times with blocking buffer containing 0.5% TWEEN-20 (Sigma Chemical Co.). Mouse antibody was detected on O'Farrell gel blots by addition of 1251I-goat antimouse Ig (0.5 MCi/ml) for 4 h at 4VC followed by washing and detection of I25l by autoradiography as previously described (27) . Mouse and rabbit antibodies on blots of single dimensional gels were detected by goat anti-mouse or anti-rabbit IgG conjugated to horseradish peroxidase (Bio-Rad Laboratories) (32) .
PMN luminol-dependent CL. PMNs were isolated from human blood by the method of Boyum (33) utilizing ficoll-hypaque density gradients and dextran sedimentation with modifications as previously described (34). These preparations contained >95% neutrophils. PMN CL assays were performed by using previously described modifications (35) mg/ml urate crystals were added to PMNs at 5 X 106 ml in I ml HBSS-0.02 M Hepes-0.25% BSA in the presence of 50 MM ferricytochrome C (Horse Heart, Sigma Chemical Co.). Experiments were performed in 5 ml polypropylene tubes at 37°C with constant agitation and the reactions were terminated by centrifugation at 500 g for 10 min at 4°C. Cell-free supernatants were decanted and superoxide dismutase-sensitive reduction of cytochrome C was assayed at 551 nm in a Gilford 240 spectrophotometer (Gilford Instrument Laboratories, Inc., Oberlin, OH) (37) . Superoxide dismutase (10 gg/ml) was added to control samples containing crystals. Control samples containing buffer in place of crystals were also included.
PMN cytolysis (LDH release) assay. Isolated PMNs in HBSS-0.02 M Hepes-0.25% BSA (6 X 106 cells/ml) and urate crystals (2.5 mg/ml) in a total volume of 0.5 ml were incubated in 5 ml polypropylene tubes at 37°C for 1 h with continuous shaking. Incubations were terminated by addition of 2 ml of iced HBSS and centrifugation at 300 g for 10 min at 4°C. Supernatants were decanted for LDH assay. Certain tubes were terminated at time zero as zero time blanks. Cell suspensions lysed by addition of Triton X-100 in HBSS (final concentration, 0.1% vol/ vol) and sonication were used to determine total enzyme activity. LDH was assayed by oxidation of NADH as previously described (18) . Results were expressed as percentage of total enzyme activity by the formula (Enzyme release -zero time blanks/total enzyme) X 100.
Other plasma and protein preparations. Plasma from an asymptomatic patient with acquired agammaglobulinemia was the generous gift of Dr. John Curd, Scripps Clinic and Research Foundation. The IgG concentration of this plasma was <38 /ig/ml by the Mancini method (38). IgM and IgA were undetectable. An aliquot of this plasma was reconstituted with addition of 15 mg/ml IgG (human Cohn fraction II, Calbiochem-Behring Corp., San Diego, CA), which was deaggregated by centrifugation at 28 psi X 30 min in a Beckman airfuge (39) . The chloramine T method was used to label IgG (40).
Fibronectin-depleted plasma and fibronectin were prepared and analyzed by gelatin-Sepharose chromatography and radioimmunoassay, respectively (41) . Sham fibronectin-depleted plasma was prepared by chromatography on underivatized Sepharose.
Clq-depleted serum was prepared by Biorex 70 chromatography, analyzed, and reconstituted with Clq as previously described (42) .
Determination ofcrystal-associated cholesterol. To ascertain if native LDL was bound to washed urate crystals, we incubated 12.5 mg/ml urate crystals in PBS buffer containing 0.8 mg/ml LDL (final concentration). Crystals were washed as described above and material was eluted from a 5 mg crystal pellet by incubation with 0.45 ml of 1 M NaCl (14) for 30 min. Urate crystals were removed by sedimentation and total cholesterol was measured in the eluate using the enzymatic spectrofluorometric assay of Heider and Boyett (43) and of Gamble et al. (44) . Samples were read in a Perkin-Elmer 650-lOS fluorescence spectrophotometer (excitation, 325 nm; emission, 415 nm) (Perkin-Elmer Corp., Norwalk, CT).
Statistical methods. Results were analyzed statistically using the Student's t test (two-tailed).
Results
Identification of apolipoproteins bound to urate crystals. We have previously noted several unidentified polypeptides selectively bound to plasma-exposed urate crystals (17) . To determine if any of these polypeptides were apolipoproteins, we compared the urate bound polypeptides of plasma and LPDP by twodimensional O'Farrell gel electrophoresis (17, 45) . Three apolipoproteins (apo A-I, apo B, and apo E) were identified among the eluted polypeptides which were consistently absent or reduced when LPDP rather than undepleted plasma was used to coat the urate crystals ( Fig. 1 , arrows numbered 1-4). The apolipoproteins showed similar mobilities to polypeptides of isolated lipoproteins on O'Farrell gels. In addition, when isolated 125I-lipoproteins were added to plasma before coating the urate crystals, the 1251 coelectrophoresed with these crystal-bound polypeptides (not shown). Details of lipoprotein class origin and apparent M, and isoelectric point (pl) for the identified apolipoproteins (apo A-I, apo B, and apo E) appear in Table I . Details ofimmunochemical identification were as follows. A polypeptide (Fig. 1, arrow number 3 ) with apparent Mr = 36,000, pI = 4.5-4.8, which was present in isolated VLDL and IDL (gels not shown), contained an epitope reactive with an apo E-specific monoclonal antibody (Fig. 2) and was thus apo E. Similarly, a polypeptide ( Fig. 1 , arrow number 4) with apparent M, = 26,000, pl = 4.6-4.8 was identified as apo A-I because it was present in isolated HDL (gels not shown) and possessed an epitope reactive with an apo A-I-specific monoclonal antibody (Fig. 2) (Fig. 2) . In addition, its migration was similar to that described by Kane et al. (46) for the apo B-26 species of LDL and it was thus identified as apo B. Polypeptide number I (Fig. 1 , apparent Mr > 250,000, pI = 7.2-8.0) was a major crystal-bound species and was observed in gels of isolated VLDL, IDL, and LDL. Its low mobility in SDS gels suggested that it represented apo B-100 (46) . However, this polypeptide was only poorly transferred electrophoretically from O'Farrell gels to nitrocellulose paper, and under these conditions, was not detected by overlay with monoclonal anti-apo B antibody. In another approach, isolated LDL and proteins eluted from urate crystals exposed to plasma were applied to 3.3-6% exponential gradient SDS-PAGE gels without prior isoelectric focusing. The gels were electrophoretically transferred to nitrocellulose, as described above, followed by overlay with two different murine monoclonal antibodies and a rabbit polyclonal antiserum specific for human LDL (Fig. 3) . Antibody binding was then detected with horseradish peroxidase-conjugated specific IgG. Polypeptides with an apparent Mr of 500,000 and 142,000, respectively, were identified immunochemically as apo B by all three antibodies in urate crystal eluates ( Fig. 3; lanes  1 a, 2 a, 3 a) . The 500,000 polypeptide was identified also in native LDL ( Fig. 3; lanes 1 b, 2 b, 3 b) and presumably represents apo B-100 (46) . Another urate-bound apo B polypeptide with apparent Mr = 300,000 was identified by murine monoclonal antibody V82B1 (lane 2 a) and seen as a closely spaced doublet with rabbit polyclonal anti-apo B serum (lane 1 a) . Inspection of the polypeptides eluted from urate crystals (Figs. 1 A, B ) also revealed that a number of polypeptides, which comigrated with minor species in isolated LDL and possessed apparent Mr from 90,000 to 94,000, were present only in reconstituted LPDP (Fig.  1 B, open-headed arrows) . These peptides probably represented apo B fragments (47, 48) . In addition, a group of low molecular weight anionic polypeptides (Fig. 1 B, curved arrow) , which comigrated with protein in VLDL, IDL, and HDL, was eluted from plasma-exposed urate crystals. These polypeptides were presumed to represent urate-bound apoprotein A-Il or one of the apoprotein C subclasses (60), but further identification was not attempted.
Effect of lipoprotein depletion ofplasma on the neutrophilurate crystal interaction. To investigate the effects of crystalbound lipoproteins on urate crystal-induced neutrophil stimulation, we utilized luminol-dependent CL. CL reflects changes in neutrophil oxidative metabolism (49) and offers the advantages of sensitivity, ease of quantitation, and kinetic measurements on a single sample. Urate crystals induced dose-dependent CL at crystal concentrations from 0.1 to 10 mg/ml (data not shown); a dose of 2 mg/ml urate crystals, which produced a slightly submaximal response, was chosen for CL experiments.
As previously described for urate crystal-induced neutrophil cytolysis (18) and superoxide generation (7), we found that plasma and serum precoating of the crystals suppressed (>50%) the CL response relative to that obtained with uncoated crystals (Fig. 4 A) . In contrast, precoating of urate crystals with LPDP led to a CL response quantitatively similar to the response to uncoated crystals (Fig. 4 B) , despite the fact that numerous plasma proteins were bound to the crystals (Fig. 1 A) . Reconstitution of LPDP with the d < 1.25 g/cm3 fraction of plasma reconstituted the plasma inhibition ofCL (Fig. 4) . When plasmas were coincubated with cells and crystals, inhibition ofCL, which was reversible by lipoprotein depletion, also was observed (data not shown).
To determine if lipoprotein-associated inhibition of urate crystal-induced CL correlated with inhibition of other cellular responses, we assayed superoxide generation and cytolysis. Precoating urate crystals with plasma (reconstituted LPDP) inhibited crystal-induced superoxide generation as expected (Table II, 50% inhibition), and this inhibition was significantly reduced by lipoprotein depletion (18% inhibition). Neutrophil lysis was assessed by urate crystal-induced lactic dehydrogenase (LDH) loss (Table III) . Lipoprotein depletion from plasma resulted in marked reduction of the suppressive effect of plasma (reconstituted LPDP) on cytolysis.
Identification ofapo B-containing lipoproteins as the major inhibitory species. To determine which lipoproteins participated in plasma inhibition of urate crystal-induced neutrophil simulation, we reconstituted LPDP with physiologic concentrations and plasma. 2.5 X 10' PMNs were incubated in HBSS buffer containing 0.02 M Hepes, 0.25% BSA, and 2 pM luminol at 220C, and background CL was determined in a Beckman LS-8000 Scintillation counter (Beckman Instruments, Inc., Fullerton, CA) in the out of coincidence mode. At zero time, additions were made in triplicate of 1 mg (2 mg/ml) urate crystals which had been coated with buffer ( X ), 5 mM EDTA plasma (-o-), 0.38% Na citrate plasma t -), and serum (-o -) from the same donor. CL was monitored for 60 min at 220C. CL values are expressed here and throughout the paper as counts per minute corrected for background observed in the absence of stimuli. All CL experiments were performed two or more times and representative experiments are shown. (B) Effect of lipoprotein depletion of plasma on inhibition of urate crystalinduced PMN CL. LPDP and reconstituted LPDP were adjusted to equal protein concentrations. Urate crystals at 25 mg/ml (0.3 ml) were incubated with 0.6 ml of these plasmas or buffer and washed. Crystals coated with buffer (-X -), LPDP (-o-), and reconstituted LPDP (-o -) were added to PMNs and CL was assayed as described.
of isolated VLDL, IDL, LDL, and HDL (50) , and used these plasmas to coat urate crystals. The washed crystals were then assayed for their ability to induce CL relative to uncoated crystals. As shown in Table IV A, LDL reconstitution had the largest inhibitory effect (78% inhibition of peak crystal-induced CL), VLDL and IDL were active (52% and 46% inhibition, respectively), and HDL was inactive. This suggested that the apo Bcontaining lipoproteins (VLDL, IDL, and LDL) were the active species. To confirm this, plasma was depleted of apo B-bearing lipoproteins by immunoaffinity chromatography (see Methods). Apo B was undetectable in the antibody adsorbed plasma (<50 ng/mg plasma protein). Apo-B depletion completely abrogated the CL inhibitory effect of plasma (Table IV B (A.) Lipoproteins were added to LPDP to restore physiologic concentrations (VLDL, 0.12 mg/ml; IDL, 0.1 mg/ml; LDL, 0.9 mg/ml; HDL, 1.5 mg/ml) and the plasmas were incubated with urate crystals. Precoated washed crystals (2 mg/ml) were added in triplicate to PMNs for assay of CL as previously described. Maximum CL refers to the highest CL observed within 30 min of the addition of the crystal stimuli. (B.) In a separate experiment, plasma was depleted of apo B by immunoaffinity chromatography employing a murine monoclonal anti-apo B antibody (V82A6). Apo B-depleted plasma and starting plasma (0.8 ml) diluted to identical protein concentrations were incubated with 0.2 ml of a 25 mg/ml urate crystal suspension. Washed precoated crystals (2 mg/ml) were subsequently added to PMNs in quadruplicate and CL was monitored. measured ( Fig. 5 B) . VLDL, IDL, and LDL were inhibitory, and LDL had the greatest quantitative effect at physiologic input concentrations. In contrast, crystal-bound HDL did not inhibit urate crystal-induced CL at the concentrations tested.
To demonstrate association of intact LDL particles with urate crystals, the washed urate crystal pellet was assayed for total cholesterol after incubation of 12.5 mg/ml crystals with a periphysiologic concentration of LDL (0.8 mg/ml). Urate crystalbound cholesterol (5.3 qg/mg urate crystal) was detected and confirmed the binding of native LDL.
Stimulus specificity of lipoprotein inhibition of CL. To determine if the inhibitory effect of apo B-containing lipoproteins on CL was stimulus-specific, we added LDL, without washing, to urate crystals, and to two other solid-phase stimuli (S. aureus and opsonized zymosan) and one fluid-phase stimulus (chemotactic hexapeptide N-formyl-N-leu-leu-phe-N-leu-tyr-lys). 10 ,ug/ml LDL (final sample concentration) inhibited the peak response to urate crystals by >80% but did not inhibit the responses to the other stimuli (Table V) .
Effects ofother plasma proteins on urate crystal-induced CL.
The quantities of protein bound to urate crystals exposed to other than the lack of lipoprotein polypeptides, the gel patterns of eluates from LPDP-coated crystals were qualitatively similar to those for plasma-coated crystals (Fig. 1) (Fig. 1) (17) . Fibrinogen did not appear to be important in inhibition of urate-induced CL as serum and plasma had similar effects (Fig. 4 A) . Plasma, depleted of fibronectin, and serum, depleted of Clq, showed no significant changes in the inhibition of CL induced by the precoated crystals (Figs. 6 A and C). In contrast, an IgG-deficient plasma was slightly more inhibitory than the same plasma reconstituted with deaggregated IgG (Fig. 6 B) . This was compatible with the previous suggestion ofa role for IgG in urate crystal stimulation ofneutrophils (7, 18) .
Discussion
When the etiologic agent ofhuman gout, the monosodium urate crystal (1, 2) is incubated with plasma, a number of proteins are selectively bound (17) . In the present work, apo A-I, apo B, and apo E were identified by electrophoresis and Western blotting techniques. Binding of intact lipoproteins to the urate crystals was substantiated by demonstration of the association of both apo B and cholesterol with the crystals after incubation with LDL. Strikingly, the bound apo B-containing lipoproteins appeared to account for virtually all of the inhibitory activity of plasma on urate-induced PMN CL and a major portion of the plasma inhibition of superoxide generation and cytolysis. This statement is based on the observation that removal ofthese lipoproteins by density gradient centrifugation or immunodepletion abrogated or markedly reduced the inhibitory effects of plasma on these reactions. Because the major apo B lipoprotein, Table I ). A number of smaller LDL-derived polypeptides visualized on silver-stained urate crystal pellet two-dimensional gels (Fig. 1, open arrows) , apparent Mr = 90,000-94,000, were not detected with monoclonal anti-apo B antibodies in the Western blot system (Figs.  2 and 3 ). These were probably apo B-related as essentially all the protein of LDL exists as apo B (60) . A possible explanation for the failure to detect these as apo B species would be the known differential immunochemical reactivity of various apo B species (27, 47) ; alternatively, proteolytic cleavage of apo B during preparation (47, 48) and incubation with urate crystals, or the denaturation carried out before electrophoresis may have rendered certain apo B peptides devoid of a suitable epitope for the apo B-specific antibodies.
We investigated the effects of plasma on urate crystal-neutrophil interaction by measurement of luminol-dependent CL, a commonly employed assay system for stimulation ofphagocyte oxidative metabolism by particulates (36) . Luminol-dependent CL depends on the generation of superoxide and hydrogen peroxide and the action of myeloperoxidase (49, 61) . Previous studies have shown that preincubation of urate crystals with plasma or serum reduces the ability of crystals to induce neutrophil superoxide generation (7) and cytolysis ( 18) . As expected, crystal preincubation with plasma and serum also inhibited CL (Fig.  4 A) . Depletion of lipoproteins from plasma by density gradient ultracentrifugation completely abrogated the inhibition of urate crystal-induced CL produced by precoating the crystals with plasma (Fig. 4 B) . Similar effects were observed on coincubation of plasmas with crystals and cells, indicating that the lipoprotein effect is not limited to coated crystals in plasma-free systems. Lipoproteins also showed similar modulatory effects on neutrophil cytolysis (LDH loss, Table III ) and superoxide generation (Table II) (Table IV A) . Second, immunodepletion of apo B lipoproteins by agarose-bound monoclonal antibody also abrogated the inhibitory activity of plasma (Table  IV B ). Since most of the circulating apo B under normal circumstances is in LDL (60) , LDL probably provides the bulk of this activity. This suggestion was borne out by the observation that physiologic reconstitution of LPDP with LDL produced a more potent inhibitory reagent than reconstitution with other lipoproteins (Table IV A) .
Because many plasma proteins are bound to these crystals, it is possible that the lipoprotein effect on urate-induced CL is mediated through another plasma protein or is a nonspecific protein effect. However, this seems unlikely for several reasons. First, with the exception of the apolipoproteins, the two-dimensional gel electrophoretic patterns ofthe crystal eluates were similar for LPDP and reconstituted LPDP (Fig. 1) (Fig. 5 A) and inhibited CL (Fig. 5 B) in the absence of other added plasma proteins. Fourth, nonspecific inhibition of urate-induced neutrophil cytolysis by plasma proteins is observed in otherwise protein-free crystal-cell suspensions (18) .
Thus, all CL, superoxide, and cytolysis assays were performed in the presence of 2-2.5 mg/ml of the "nonspecific protein" BSA, so that additional inhibitory effects, such as those of lipoproteins, could be assessed. Fifth, HDL, bound to crystals in amounts similar to VLDL and IDL, failed to inhibit urateinduced CL (Figs. 5 A and B) . Finally, plasmas or sera deficient in, or depleted of, three other major urate-binding plasma proteins still were potent inhibitors of urate-induced CL (Fig. 6) .
The ability ofapo B-containing lipoproteins to inhibit urateinduced CL was not due to interference with the CL assay or to direct toxic effects on the cells, since response to fluid-phase chemotactic hexapeptide was not reduced by doses of LDL which produced 80% inhibition of urate-induced CL (Table V) . In addition, the possibility that inhibition was due to nonspecific effects on PMN-particle interaction or phagocytosis was less likely since responses to two other particulates were unaffected by LDL. Elucidation of this novel functional property of apo B-containing lipoproteins will require detailed studies of their effects on other events which follow PMN-crystal interaction, effects with other crystals and cell types, and the lipoprotein structural requirements for this activity. It has been suggested that LDL is a major plasma regulator of HeLa cell adhesion to glass (62) , which is a negatively charged surface like monosodium urate crystals. In addition, there is evidence that human serum enhances the stimulation by urate crystals ofnonmitogenic synovial fibroblast responses in vitro (63, 64 (19, (55) (56) (57) (58) , LDL may well represent an important factor in modulation of gouty inflammation.
